Cost-effectiveness of everolimus-eluting versus bare-metal stents in ST-segment elevation myocardial infarction: An analysis from the EXAMINATION randomized controlled trial

BACKGROUND: Use of everolimus-eluting stents (EES) has proven to be clinically effective and safe in patients with ST-segment elevation myocardial infarction but it remains unclear whether it is cost-effective compared to bare-metal stents (BMS) in the long-term. We sought to assess the cost-effecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Schur, Nadine, Brugaletta, Salvatore, Cequier, Angel, Iñiguez, Andrés, Serra, Antonio, Jiménez-Quevedo, Pilar, Mainar, Vicente, Campo, Gianluca, Tespili, Maurizio, den Heijer, Peter, Bethencourt, Armando, Vazquez, Nicolás, Valgimigli, Marco, Serruys, Patrick W., Ademi, Zanfina, Schwenkglenks, Matthias, Sabaté, Manel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095536/
https://www.ncbi.nlm.nih.gov/pubmed/30114230
http://dx.doi.org/10.1371/journal.pone.0201985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095536/
https://www.ncbi.nlm.nih.gov/pubmed/30114230
http://dx.doi.org/10.1371/journal.pone.0201985

Ejemplares similares